1. Puerarin inhibits bladder cancer cell proliferation through the mTOR/p70S6K signaling pathway
   Kehua Jiang et al, 2017, Oncology Letters CrossRef
2. A Critical Review on Anticancer Mechanisms of Natural Flavonoid Puerarin
   Manikanta Murahari et al, 2020, Anti-Cancer Agents in Medicinal Chemistry CrossRef
3. Puerarin: An Anticancer and Anti-Inflammatory Agent
   Harinder Singh et al, 2024, Recent Patents on Anti-Cancer Drug Discovery CrossRef
4. Integrating Chinese and Western medicines reduced the incidence of hepatocellular carcinoma in patients with diabetes mellitus: A Taiwanese population-based cohort study
   Han-Lin Lu et al, 2020, Complementary Therapies in Medicine CrossRef
5. Puerarin inhibits hepatocellular carcinoma invasion and metastasis through miR-21-mediated PTEN/AKT signaling to suppress the epithelial-mesenchymal transition
   Yuan Zhou et al, 2020, Brazilian Journal of Medical and Biological Research CrossRef
6. Puerarin attenuates cisplatin-induced rat nephrotoxicity: The involvement of TLR4/NF-κB signaling pathway
   Xu Ma et al, 2017, PLOS ONE CrossRef
7. Carnosic acid induces apoptosis of hepatocellular carcinoma cells via ROS-mediated mitochondrial pathway
   Xinrui Zhang et al, 2017, Chemico-Biological Interactions CrossRef
8. Puerarin promotes DUSP1 expression by regulating miR‑133a‑3p in breast cancer
   Zhifeng Li et al, 2018, Molecular Medicine Reports CrossRef
9. Prescription frequency and patterns of Chinese herbal medicine for liver cancer patients in Taiwan: a cross-sectional analysis of the National Health Insurance Research Database
   Chin-Tsung Ting et al, 2017, BMC Complementary and Alternative Medicine CrossRef
10. Scandenolone, a natural isoflavone derivative from Cudrania tricuspidata fruit, targets EGFR to induce apoptosis and block autophagy flux in human melanoma cells
    Yunfeng Hu et al, 2017, Journal of Functional Foods CrossRef
11. The protective effect of puerarin on angiotensin II‑induced aortic aneurysm formation by the inhibition of NADPH oxidase activation and oxidative stress‑triggered AP‑1 signaling pathways
    Jie Yue et al, 2018, Oncology Letters CrossRef
12. RETRACTED: Puerarin 6″‐O‐xyloside suppressed HCC via regulating proliferation, stemness, and apoptosis with inhibited PI3K/AKT/mTOR
    Long Li et al, 2020, Cancer Medicine CrossRef
13. Phytochemicals Mediate the Expression and Activity of OCTN2 as Activators of the PPARγ/RXRα Pathway
    Jian Luo et al, 2016, Frontiers in Pharmacology CrossRef
14. Puerarin attenuates the daunorubicin-induced apoptosis of H9c2 cells by activating the PI3K/Akt signaling pathway via the inhibition of Ca2+ influx
    Weihua Li et al, 2017, International Journal of Molecular Medicine CrossRef
15. Puerarin Inhibits Proliferation and Induces Apoptosis by Upregulation of miR-16 in Bladder Cancer Cell Line T24
    Xiaoyun Liu et al, 2018, Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics CrossRef
16. Investigating the solid-liquid extraction process of puerarin by molecular dynamics simulations
    Yuefei Zhang et al, 2019, International Journal of Heat and Mass Transfer CrossRef
17. Puerarin: a hepatoprotective drug from bench to bedside
    Yi-Xiang He et al, 2024, Chinese Medicine CrossRef
18. Apoptotic effects on maturation of mouse oocytes, fertilization and fetal development by puerarin
    Fu-Jen Huang et al, 2016, Drug and Chemical Toxicology CrossRef
19. Retracted: Effects and mechanism of puerarin on the human retinoblastoma cells
    Chao Yang et al, 2018, Journal of Cellular Biochemistry CrossRef
20. Paeoniflorin influences breast cancer cell proliferation and invasion via inhibition of the Notch‑1 signaling pathway
    Jing Zhang et al, 2017, Molecular Medicine Reports CrossRef